MedTrace Logo

Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event

NCT04872075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6678

Last updated 2025-11-20

No results posted yet for this study

Summary

The objective is to demonstrate if there is no increase in the risk of Sars-Cov-2 salivary carriage 7 days after a concert in the group participating in the event compared to a non participating group who stayed at home.

The hypothesis is that a systematic screening of Sars-Cov-2 within the 3 days before the event allows to control the risk of transmission and prevent cluster of transmission during the concert.

Conditions

  • Covid19

Interventions

OTHER

Concert

People attending a concert in a closed area, with a mask

DIAGNOSTIC_TEST

Rapid nasopharyngeal antigen test for Sars-Cov-2

A nasopharyngeal swab at inclusion (up to 3 days before concert) to confirm eligibility

DIAGNOSTIC_TEST

Saliva Sample

Saliva samples sent by participant at Day0 and Day7

Sponsors & Collaborators

  • PRODISS

    collaborator UNKNOWN

  • WEEZEVENT

    collaborator UNKNOWN

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Constance DELAUGERRE, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-26
Primary Completion
2021-06-13
Completion
2021-06-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04872075 on ClinicalTrials.gov